Jean‐Pierre Pignon

48.3k total citations · 18 hit papers
305 papers, 31.0k citations indexed

About

Jean‐Pierre Pignon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jean‐Pierre Pignon has authored 305 papers receiving a total of 31.0k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Oncology, 140 papers in Pulmonary and Respiratory Medicine and 66 papers in Surgery. Recurrent topics in Jean‐Pierre Pignon's work include Lung Cancer Treatments and Mutations (95 papers), Head and Neck Cancer Studies (63 papers) and Lung Cancer Diagnosis and Treatment (61 papers). Jean‐Pierre Pignon is often cited by papers focused on Lung Cancer Treatments and Mutations (95 papers), Head and Neck Cancer Studies (63 papers) and Lung Cancer Diagnosis and Treatment (61 papers). Jean‐Pierre Pignon collaborates with scholars based in France, United States and United Kingdom. Jean‐Pierre Pignon's co-authors include Jean Bourhis, Aurélie Le Maître, C. Domenge, E. Maillard, Thierry Le Chevalier, R. Arriagada, Lesley Stewart, Michel Ducreux, C. Le Péchoux and Valérie Boige and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jean‐Pierre Pignon

294 papers receiving 30.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

2009 2.1k citations Jean‐Pierre Pignon, Aurélie Le Maître et al. Radiotherapy and Oncology profile →
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

2000 1.9k citations Jean‐Pierre Pignon, Jean Bourhis et al. profile →
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

2008 1.8k citations Jean‐Pierre Pignon, Hélène Tribodet et al. Journal of Clinical Oncology profile →
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

2011 1.5k citations Marc Ychou, Valérie Boige et al. Journal of Clinical Oncology profile →
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

2010 1.3k citations Anne Aupérin, C. Le Péchoux et al. Journal of Clinical Oncology profile →
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

2006 1.3k citations Ariane Dunant, Élisabeth Brambilla et al. profile →
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

1999 1.2k citations R. Arriagada, Jean‐Pierre Pignon et al. profile →
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

1992 932 citations Jean‐Pierre Pignon, R. Arriagada et al. profile →
Immunogenic death of colon cancer cells treated with oxaliplatin

2009 917 citations Valérie Boige, Jean Mendiboure et al. profile →
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.

1998 789 citations Marc Buyse, Jean‐Pierre Pignon et al. Journal of Clinical Oncology profile →
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

2006 752 citations Jean Bourhis, Jens Overgaard et al. profile →
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer

2001 583 citations Jean‐Pierre Pignon, Jean Bourhis et al. profile →
Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials

1998 580 citations Sarah Burdett, Lesley Stewart et al. profile →
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

2017 554 citations B. Lueza, Jean-Yves Douillard et al. Annals of Oncology profile →
A graphical method for exploring heterogeneity in meta‐analyses: application to a meta‐analysis of 65 trials

2002 498 citations B. Baujat, Jean‐Pierre Pignon et al. profile →
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

2000 465 citations Jean‐Pierre Pignon profile →
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

2010 444 citations R. Arriagada, A. Aupérin et al. profile →
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site

2011 431 citations Pierre Blanchard, B. Baujat et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Jean‐Pierre Pignon

Since Specialization

Citations

This map shows the geographic impact of Jean‐Pierre Pignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Pignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Pignon more than expected).

Fields of papers citing papers by Jean‐Pierre Pignon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Pignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Pignon. The network helps show where Jean‐Pierre Pignon may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Pignon

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Pignon. A scholar is included among the top collaborators of Jean‐Pierre Pignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Pignon. Jean‐Pierre Pignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses 2023 ·Radiotherapy and Oncology ·Elaine Johanna Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh‐Thu Le, Sue S. Yom, Catherine Fortpied, Johannes A. Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean‐Pierre Pignon, Anne Aupérin	1
2	Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas 2019 ·Systematic Reviews ·Claire Petit, Pierre Blanchard, Jean‐Pierre Pignon, B. Lueza	11
3	Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience 2018 ·BMJ Open ·(unknown), Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon	3
4	Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973) 2018 ·BMC Cancer ·Diane Goèré, Jean‐Pierre Pignon, Maximiliano Gelli, Dominique Elias, Léonor Benhaïm, Frédèric Deschamps, Caroline Caramella, Valérie Boige, Michel Ducreux, Thierry de Baère, David Malka	26
5	Investigating the heterogeneity of alkylating agents’ efficacy and toxicity between sexes: A systematic review and meta‐analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study) 2017 ·Pediatric Blood & Cancer ·Brice Fresneau, Allan Hackshaw, Douglas S. Hawkins, Michael Paulussen, J R Anderson, Ian Judson, Saskia Litière, Uta Dirksen, I J Lewis, Henk van den Berg, Nathalie Gaspar, Hans Gelderblom, Jeremy Whelan, Alan V. Boddy, K. Wheatley, Jean‐Pierre Pignon, Florent de Vathaire, Marie‐Cécile Le Deley, Gwénaël Le Teuff	7
6	Méta-analyses en réseau : intérêt et limites en oncologie 2016 ·Bulletin du Cancer ·Laureen Ribassin-Majed, Jean‐Pierre Pignon, Stefan Michiels, Pierre Blanchard	0
7	Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer 2015 ·Annals of Oncology ·Éric Deutsch, C. Le Péchoux, Laurence Faivre, Sofía Rivera, Yungan Tao, Jean‐Pierre Pignon, (unknown), Rastilav Bahleda, Désirèe Deandreis, Eric Angevin, C. Hennequin, Benjamin Besse, Antonin Lévy, Jean‐Charles Soria	42
8	Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial breakdown → 2011 ·Journal of Clinical Oncology ·Marc Ychou, Valérie Boige, Jean‐Pierre Pignon, Thierry Conroy, Olivier Bouché, G. Lebreton, (unknown), Laurent Bedenne, (unknown), B. Saint‐Aubert, Jean Genève, P Lasser, P. Rougier	1484
9	PRE-OPERATIVE CHEMOTHERAPY IMPROVES SURVIVAL AND REDUCES RECURRENCE IN OPERABLE NON-SMALL CELL LUNG CANCER: PRELIMINARY RESULTS OF A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 13 RANDOMISED TRIALS 2011 ·UCL Discovery (University College London) ·Sarah Burdett, (unknown), Jayne F. Tierney, Jean‐Pierre Pignon, (unknown)	2
10	Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3 2011 ·European Respiratory Journal ·Isabelle Borget, Jacques Cadranel, Jean‐Pierre Pignon, Élisabeth Quoix, Bruno Coudert, Virginie Westeel, Éric Dansin, J. Madelaine, Anne Madroszyk, S. Friard, Catherine Daniel, Franck Morin, C. Chouaïd, (unknown)	27
11	MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma 2010 ·Cancer Research ·Johannes Voortman, Akiteru Goto, Jean Mendiboure, Jane J. Sohn, Aaron J. Schetter, Motonobu Saito, Ariane Dunant, Trung C. Pham, Iacopo Petrini, (unknown), Khan Ma, Pierre Hainaut, Jean‐Pierre Pignon, Élisabeth Brambilla, Helmut Popper, Martin Filipits, Curtis C. Harris, Giuseppe Giaccone	109
12	Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer breakdown → 2010 ·Journal of Clinical Oncology ·Anne Aupérin, C. Le Péchoux, Estelle Rolland, Walter J. Curran, Kiyoyuki Furuse, P. Fournel, J. Belderbos, Gerald H. Clamon, H Cüneyt Ulutin, Rebecca Paulus, Takeharu Yamanaka, Marie‐Cécile Bozonnat, A. L. J. Uitterhoeve, Xiaofei Wang, Lesley Stewart, R. Arriagada, Sarah Burdett, Jean‐Pierre Pignon	1329
13	Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05 2010 ·American Journal of Clinical Oncology ·Valérie Boige, Jean Mendiboure, Jean‐Pierre Pignon, (unknown), Marine Castaing, Michel Barrois, (unknown), (unknown), Olivier Bouché, (unknown), Isabelle Miran, Claire Mulot, Michel Ducreux, Philippe Beaune, Pierre Laurent‐Puig	3
14	Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer 2008 ·Journal of Clinical Oncology ·Martin Früh, Estelle Rolland, Jean‐Pierre Pignon, Lesley Seymour, Keyue Ding, Hélène Tribodet, Timothy Winton, Thierry Le Chevalier, Giorgio V. Scagliotti, Jean-Yves Douillard, Stephen Spiro, Frances A. Shepherd	132
15	Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group 2008 ·Journal of Clinical Oncology ·Sarah Burdett, RJ Stephens, Lesley Stewart, Jayne F. Tierney, A. Aupérin, T. Le Chevalier, C. Le Péchoux, Jean‐Pierre Pignon, R. Arriagada, (unknown), D. Johnson, Jan P. van Meerbeeck, Max Parmar, R L Souhami, (unknown)	165
16	Critical issues in colorectal cancer trial design 2007 ·Document Server@UHasselt (UHasselt) ·Pascal Piedbois, Marc Buyse, Jean‐Pierre Pignon	0
17	Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program 2007 ·Clinical Cancer Research ·Martin Filipits, Vincent Haddad, Katharina Schmid, Anh Tuan Huynh, Ariane Dunant, Fabrice André, Élisabeth Brambilla, Rolf A. Stahel, Jean‐Pierre Pignon, Jean‐Charles Soria, Helmut Popper, Thierry Le Chevalier, Robert Pirker	66
18	Individual patients' data meta-analyses in head and neck cancer 2007 ·Current Opinion in Oncology ·Jean Bourhis, Aurélie Le Maître, B. Baujat, Hélène Audry, Jean‐Pierre Pignon	104
19	Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-Analysis 2004 ·Journal of Clinical Oncology ·P. Thirion, Stefan Michiels, Jean‐Pierre Pignon, Marc Buyse, A.C. Braud, Robert W. Carlson, M. O’Connell, Penny Sargent, (unknown)	304
20	[Meta-analysis in clinical research]. 1988 ·PubMed ·Jean‐Pierre Pignon	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact